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Open access under the ElEstrogens are a class of micro-pollutants found in water at low concentrations (in the ng L1 range), but
often sufﬁcient to exert estrogenic effects due to their high estrogenic potency. Disinfection of waters
containing estrogens through oxidative processes has been shown to lead to the formation of disinfection
byproducts, which may also be estrogenic. The present work investigates the formation of disinfection
byproducts of 17b-estradiol (E2) and estrone (E1) in the treatment of water with ozone. Experiments
have been carried out at two different concentrations of the estrogens in ground water (100 ng L1 and
100 lg L1) and at varying ozone dosages (0–30 mg L1). Detection of the estrogens and their disinfection
byproducts in the water samples has been performed by means of ultra performance liquid chromatog-
raphy–tandemmass spectrometry (UPLC–MS/MS) with a triple quadrupole (QqQ) and a quadrupole-time
of ﬂight (QqTOF) instrument. Both E2 and E1 have been found to form two main byproducts, with molec-
ular mass (MM) 288 and 278 in the case of E2, and 286 and 276 in the case of E1, following presumably
the same reaction pathways. The E2 byproduct with MM 288 has been identiﬁed as 10epsilon-17beta-
dihydroxy-1,4-estradieno-3-one (DEO), in agreement with previously published results. The molecular
structures and the formation pathways of the other three newly identiﬁed byproducts have been sug-
gested. These byproducts have been found to be formed at both high and low concentrations of the estro-
gens and to be persistent even after application of high ozone dosages.
 2011 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction water (Kuster et al., 2008; Yoon et al., 2010). If present in the waterOzone can be used in the drinking water process, since it is a
powerful oxidant and disinfectant. However, it can form disinfec-
tion byproducts through oxidation with inorganic and organic
compounds (Richardson, 2003).
The presence of some ozonation disinfection byproducts (DBPs),
like bromate, trihalomethanes (THMs) and haloacetic acids (HAAs),
is regulated in drinkingwater to control andminimize human expo-
sure to thesehazardous compounds (European-Communities, 1998;
USEPA, 2009). However, there are potentially manymore ozonation
DBPs, and until 2003 only less than 50% of the assimilable organic
carbon (AOC) formed during ozonation of water has been character-
ized (Richardson, 2003).
Compounds such as 17b-estradiol (E2) and estrone (E1), which
have endocrine disrupting properties, are often found in surfacedraulics and Sanitation of the
, Campus de São Carlos, Av.
Carlos, São Paulo 13566-590,
ira Pereira).
sevier OA license.used as source for abstraction of drinking water these micro-pollu-
tants can react with ozone forming disinfection byproducts that
can pose a potential risk to the population served with this water.
Sewage treatment efﬂuents are one of the main sources of
estrogens in the aquatic environment. The extent of their degrada-
tion during sewage treatment and their subsequent load into the
receiving natural waters is variable, depending on the type of treat-
ment applied, the hydraulic residence time, the sludge retention
time, and other operational factors (Cargouet et al., 2004; Auriol
et al., 2006; Esperanza, 2007). Furthermore, since estrogens are fe-
male sex hormones naturally produced by vertebrates, non-point
sources, especially in rural areas with intense farming activities,
may also be relevant (Ying et al., 2009).
Of the various natural and synthetic free estrogens E1 and E2 are
the most frequently detected. Their mean/median efﬂuent concen-
trations in wastewater are situated in the range of 20–55 ng L1
for E1 and 9–20 ng L1 for E2 (D’Ascenzo et al., 2003). Meanwhile,
in surfacewater the concentrations reported for these twoestrogens
in the last years have ranged between 0.7 and 143 ng L1 for E1
(Rodriquez-Mozaz et al., 2004a,b; Ying et al., 2009) and between
1.4 and 34 ng L1 for E2 (Chen et al., 2007; Ying et al., 2009).
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E2, alike other estrogens and endocrine disrupting compounds
(EDCs), are usually gradually and efﬁciently, although not neces-
sarily completely, removed (Chen et al., 2007; Chang, 2009). Thus,
E2 and E1 have been detected, for instance, in ﬁnished drinking
water from Brazil at concentrations up to 6.8 ng L1 and 0.1 ng L1,
respectively (Gerolin, 2008; Lopes et al., 2010; Sodre et al., 2010).
However, in general, the treatments applied in drinking water
treatment plants (DWTPs) are successful at removing estrogens,
i.e., at eliminating the parent compounds (although this does not
necessarily imply full elimination by e.g. mineralization), and oxi-
dation by ozone and chlorine are among the most effective and
extensively used processes (Benotti et al., 2009b). Other oxidants,
apart from ozone and chlorine (Alum et al., 2004; Kim et al.,
2004; Deborde et al., 2005; Westerhoff et al., 2005; Hashimoto
et al., 2006; Bila et al., 2007; Maniero et al., 2008; Broséus et al.,
2009; Lin et al., 2009), that have been studied for the removal of
estrogens (parent compound) from water have been chlorine diox-
ide (Huber et al., 2005), photolysis (Mazellier et al., 2008), photo-
Fenton (Yaping and Jiangyong, 2008; Zhao et al., 2008), titanium
dioxide photocatalysis (TiO2/UV) (Ohko et al., 2002; Zhang et al.,
2007; Benotti et al., 2009a), ferrate (Lin et al., 2009), electrochem-
ical degradation (Murugananthan et al., 2007) and sonolysis (Suri
et al., 2007). In comparison with most of these oxidants, ozone pre-
sents the advantage of having high rate constants (Huber et al.,
2005) and being a powerful disinfectant.
Typical doses of ozone (<2 mg L1) applied during treatment of
water containing E1 and E2 have reached 96–99% removal of the
parent compound (Alum et al., 2004; Kim et al., 2004; Westerhoff
et al., 2005; Bila et al., 2007; Maniero et al., 2008; Broséus et al.,
2009). However, some works have reported the formation of
byproducts after the removal of E1 and E2 (Pereira et al., 2011).
In this context, the objective of this work was to investigate the
formation of E1 and E2 byproducts during ozonation, to try to iden-
tify them, and to estimate the dose of ozone necessary for the com-
plete removal of these byproducts.2. Materials and methods
2.1. Reagents and solutions
HPLC-grade acetone, methanol and water were supplied by
Merck (Darmstadt, Germany). Pure standards of 17b-estradiol
(E2), estrone (E1), 6a-hydroxyestradiol, 4-hydroxyestradiol, and
2-hydroxyestradiol were purchased from Sigma Aldrich (Stein-
heim, Germany). Individual stock solutions of the analytes were
prepared at 100 mg L1 by dissolving 10 mg of each compound in
100 mL of methanol. Estrogens in methanol solutions stored in
the dark at 4 C are stable for at least 6 months. The solutions at
100 lg L1 and 100 ng L1 were freshly prepared before every
batch of experiments by appropriate dilution of the individual
stock solutions in ground water.
Ground water from the University of São Paulo (São Carlos Cam-
pus, Brazil) collected before chlorination was used to carry out the
assays. After collection it was stored at 4 C until use. This water
source was chosen because of the similarity of its characteristics
with those of drinking water, with the required quality in terms
of average turbidity (0.4 ± 0.2 NTU) and average color
(1.0 ± 1.5 Pt-Co units).2.2. Ozonation experiments
The ozonation experiments were carried out in a pilot scale
experimental unit (Supplementary Information-1). The ozonation
reactor had a total height of 3.5 m, a working height of 3.0 m, anexternal diameter of 110 mm and a volume of 28.5 L. The ozone
generator (EAGLESAT, Brazil) was a corona discharge type and
had an oxygen generation unit (PSA method – Pressure Swing
Adsorption) and a compressor to generate ozone. The production
of ozone in the gas phase was measured with an ozone analyzer
(IN USA, ASX-Mod H1) coupled to a rotameter. The ozone was ap-
plied to the base of the reactor using a porous diffuser and the off-
gas was captured in a ﬂask containing potassium iodide solution at
2% (w/w). The total ozone consumed was calculated according to
following equation:
CO ¼ AO OF RO ð1Þ
where CO is the consumed ozone (mg L1), AO is the applied ozone
(mg L1), OF is the ozone in the off-gas (mg L1), and RO is the resid-
ual ozone in the liquid phase (mg L1). Therefore, the concentration
of ozone expressed in the present work is the ozone consumed dur-
ing the reaction time.
Experiments were performed at two different initial concentra-
tions of E2 and E1 (100 lg L1 and 100 ng L1), in separated
batches for each estrogen and one treatment was done for each
dose of ozone (batch experiments). The experiments at 100 lg L1
were conducted ﬁrst. The objective in this case was to identify the
main byproducts formed during ozonation. Then the experiments
at 100 ng L1 were performed in order to track and conﬁrm the
presence of the previously identiﬁed byproducts but at concentra-
tions closer to those found in real samples (surface water). In all
cases the dose of ozone applied ranged from 0.4 to 28 mg L1,
the temperature was set at 19 ± 2 C and the natural pH of the
ground water at the beginning of the treatments was 7.0 ± 0.3.
After the ozone application, aliquots of 200 mL were withdrawn
from the reactor and the residual ozone in the water samples was
measured by indigo colorimetric method 4500-O3 B (APHA, 1998)
immediately after the assays.
2.3. Analysis
2.3.1. Sample preparation
Samples (200 mL) were preconcentrated by solid phase extrac-
tion (SPE) with C18 cartridges (Accubond, 500 mg) from Agilent
Technologies (Santa Clara, CA, USA) following a procedure adapted
from Ternes et al. (1999). After sample loading the cartridges were
rinsed with 10 mL of HPLC water and eluted with 4 mL of acetone.
Main differences with respect to the method described by Ternes
et al. (1999) refer to the sample volume (200 mL vs 1 L) and the
performance of a washing step of the cartridge prior to elution.
The extracts obtained were then blown down to dryness under
nitrogen, reconstituted with methanol to a ﬁnal volume of
0.5 mL, and stored in the dark at 4 C for subsequent LC–MS/MS
analysis. Under these conditions both E1 and E2 are stable for at
least 60 d (recovery percentage ± relative standard deviation equal
to 96 ± 1% and 102 ± 5% for E1 and E2, respectively).
2.3.2. Identiﬁcation of byproducts by UPLC–QqToF-MS/MS
Identiﬁcation of E1 and E2 ozonation byproducts in the water
samples extracts coming from the experiments performed at
100 lg L1 (see Section 2.2) was carried out by UPLC–QqTOF-MS/
MS on a Waters Acquity UPLC system (Waters Corp., Mildford,
MA) equipped with a binary solvent delivery system and an auto-
sampler coupled to a Waters QqToF-Micro MS/MS detector. Chro-
matographic separation was performed on a Hibar HR Purospher
STAR RP-18 column (30  2.1 mm, 2 lm particle size) from Merck
(Darmstadt, Germany). The column temperature was set to 35 C
and the samples compartment temperature was kept to 10 C.
The injection volume was 5 lL and the column ﬂow rate
0.4 mL min1. The mobile phase consisted of A (acetonitrile) and
B (water). The gradient started with 10% A, composition that was
Fig. 1. Degradation of E1 and E2 during ozonation in the experiments carried out
with an initial concentration of the estrogens in water of 100 lg L1.
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2 min, kept constant for 1 min, linearly increased to 50% A over
1 min, kept constant for 2 min, raised to 100% A in 2 min, maintain
constant for 1 min, and decreased to 10% A within 1 min. Total run
time, including reequilibration of the column to the initial condi-
tions, was 12 min.
Detection was performed with an electrospray (ESI) interface in
the negative ionization (NI) and with the capillary voltage set to
2800 V and cone voltages varying between 10 and 50 V. TheFig. 2. Mass-to-charge (m/z) ratio and retention time of the main byproducts identiﬁed w
concentration of the estrogens in water of 100 lg L1.nebulization gas (nitrogen) was set to 500 L h1 at a temperature
of 450 C; the cone gas (nitrogen) was set to 30 L h1, and the
source temperature to 150 C. For MS experiments, the instrument
was operated in a wide pass quadrupole mode with the TOF data
being collected between m/z 50 and 600 and low collision energy
(CE) of 4 eV. The product ion MS/MS experiments were performed
at variable CE (10–50 eV). All analyses were performed using an
independent reference spray (lockSpray) to ensure accuracy and
reproducibility. Val-Tyr-Val was used as lock mass (m/z
380.2029) for internal mass calibration.
Instrument control, data acquisition, and evaluation were done
by means of MassLynx V4.1 software (Waters Corp.). This software
(Waters Corp.) calculates all possible elemental compositions for a
given accurate mass and is thus a potent tool for hypothesizing
possible structures of unknown compounds. Final identiﬁcation
can then be performed based on the accurate mass measurements
of the parent ions and fragments obtained in MS/MS experiments.2.3.3. Analysis of byproducts by UPLC–QqQ-MS/MS
Analysis of the previously identiﬁed byproducts in the water
extracts coming from the experiments performed at low initial
concentration of estrogens (100 ng L1) was carried out by
UPLC–QqQ-MS/MS on a Waters Acquity UPLC system coupled to
a Waters TQD MS/MS detector. Chromatographic conditions were
the same as described above for UPLC–QqToF-MS/MS analysisith different doses of ozone in the degradation of: (A) E1 and (B) E2 with an initial
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analysis of E2 treated with 16.7 mg O3 L1 and from the analysis of standards of
4OH-E2, 2OH-E2 and 6OH-E2.
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sensitivity. MS/MS detection was performed in the selected
reaction monitoring (SRM) mode using ESI in the NI mode andm/z
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Fig. 4. Product ion mass spectra obtained from the UPLC–QqTOF-MS/MS analysis of (A) a
ion 285), and suggested corresponding structures. Cone voltage, 30 V; CE, 20 eV.basically the same MS/MS conditions described above: capillary
voltage, 2800 V; nebulization gas ﬂow rate, 650 L h1; desolvation
temperature, 450 C; cone gas ﬂow rate, 30 L h1; source tempera-
ture, 150 C. SRM transitions and the cone and collision voltages
selected for the monitoring of the previously identiﬁed byproducts
is showed in Supplementary Information-2. Optimization of these
conditions was performed with the samples coming from the high
concentration experiments conducted before. Instrument control
and data acquisition and evaluation were done with the software
MassLynx V4.1.3. Results and discussion
Fig. 1 shows the disappearance of E1 and E2 during ozonation in
the experiments conducted with initial concentration of 100 lg L1
of the estrogens in water. As it can be seen, both estrogens vanish
rapidly, although the reaction of ozone with E1 is slightly faster
than with E2. Parallel to the disappearance of the estrogens, a
number of other new peaks appear in the UPLC–QqTOF-MS chro-
matograms obtained throughout the experiments. The m/z ratios
and the corresponding retention times of the major peaks identi-
ﬁed in the degradation of E1 and E2 are depicted in Fig. 2. The main
byproducts of E1 (with nominal m/z ratios 285, 275, 301, and 305)
are similar to those of E2 (with nominal m/z ratios 287, 277, 303,
and 307) with a difference of two mass units between them, which
coincides with the difference of two mass units also in the molec-
ular mass (MM) of the parent compounds (270.36608 g/mol for E1
and 272.38196 g/mol for E2). Since this difference is due to the
presence of a ketone group in position 17 of the molecular struc-
ture of E1 and a hydroxyl group in the same position of the E2 mol-
ecule, it is clear that ozone attacks the aromatic moiety, where the
high electronic densities on the carbons located in the ortho and
para positions favor the process (Fig. 1).
In both cases the most abundant and persistent byproducts are
the ones with lower m/z ratios: 285 and 275 for E1, and 287 and
277 for E2. The other byproducts, withm/z 301 and 305 in the case
of E1, and m/z 303 and 307 in the case of E2, are formed in much
less quantity and are therefore not considered further for
discussion.
Fig. 2A shows that the E1 byproduct withm/z 285 is fairly stable
until an ozone dosage of 12 mg O3 L1, decreasing thereafter but
not disappearing. Meanwhile the compound with m/z 275 and
retention time 4.27 min rises until the ozone dosage reaches
16.7 mg O3 L1 and its concentration keeps fairly constant after-
wards. As it is shown in Fig. 2B, the E2 byproducts show a ratherm/z
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Fig. 6. Product ion mass spectra and purported fragmentation of the byproducts
with m/z 277 (A) and m/z 275 (B) formed during ozonation of E2 and E1,
respectively.
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287 starts to decrease at a lower ozone dosage, 4.0 mg O3 L1, than
the E1 byproduct with m/z 285.
The elemental compositions proposed by the Masslynx soft-
ware for the experimental accurate masses measured by the
QqTOF-MS/MS detector, after applying basic organic chemical
rules to eliminate nonfeasible formulae and possible degradation
scenarios for the parent compounds, were C18H23O3 for m/z 287
and C16H21O4 for m/z 277. However, considering the structure of
E2 and that the most probable attack occurs at the aromatic ring
(high electronic densities) there are more than one possible struc-
ture for m/z 287 or, in other words, with mass 288. The structures
proposed so far in the scientiﬁc literature for E2 disinfection
byproducts with molecular mass 288 have been: 2-hydroxyestra-
diol (2OH-E2), identiﬁed by both Bila et al. (2007) and Maniero
et al. (2008), monohydroxylated E2 (Irmak et al., 2005), 10e-17b-
dihydroxy-1,4-estradieno-3-one (DEO) (Bila et al., 2007) and tes-
tosterone (Bila et al., 2007; Maniero et al., 2008) in ozonation
experiments. In experiments performed with other types of
oxidation processes such as, photo-Fenton, photolysis, or TiO2 pho-
tocatalysis the compounds previously identiﬁed were: 6-hydroxy-
estradiol (6OH-E2) (Mazellier et al., 2008; Zhao et al., 2008), again
2OH-E2, testosterone (Ohko et al., 2002; Zhao et al., 2008) and DEO
(Mai et al., 2008; Zhao et al., 2008). The E2 byproduct with mass
278 (m/z 277) has never been reported in the literature.
Trying to elucidate the structure of the byproduct with mass
288 the standards that were available (2OH-E2, 4OH-E2, and
6OH-E2) were acquired and analyzed. However, as it can be seen
in Fig. 3 the retention times of the standards 2OH-E2 (5.69 min)
and 4OH-E2 (5.79 min) were very different from the retention time
of the E2 byproducts with MM 288 (4.05 and 4.36 min) detected in
our ozonation experiments (16.7 mg O3 L1). On the contrary the
retention time of the standard 6OH-E2 (3.99 min) was quite simi-
lar, but when the molecules were fragmented their fragments were
totally different from each other, indicating that 6OH-E2 is not the
targeted byproduct. The standard of estriol (E3), which also has a
MM of 288, was tested as well, but the LC–MS data did not ﬁt
either. Apart from these there are other structure possibilities for
MM 288, but these structures do not have their corresponding
counterparts for MM 286 when the same degradation mechanism
is applied to the E1 molecule. The compound testosterone was also
disregarded because its formulae (C19H28O2) contains only two
oxygens (instead of three). Thus the byproduct with MM 288 is ex-
pected to be the compound named DEO. DEO was suggested by
Ohko et al. in 2002 as byproduct in the mechanism of degradation
of E2 by TiO2 photocatalysis (Ohko et al., 2002) and furtherconﬁrmed by Mai et al. in 2008 in similar oxidative processes by
LC–MS/MS analysis (Mai et al., 2008). Furthermore, the fragments
observed by Mai et al. (2008) were similar to those found in the
present study.
The fragmentation of the E2 and E1 byproducts with m/z 287
and m/z 285, respectively, is shown in Fig. 4. The part marked in
the square is virtually identical, i.e., presents the same fragment
ions, in both compounds, whereas the circled part shows a similar
fragmentation pattern but with a difference of two mass units.
Based on these spectra and on previously published works (Ohko
et al., 2002; Bila et al., 2007; Mai et al., 2008; Zhao et al., 2008)
the E2 byproduct withm/z 287 is believed to be DEO, and the main
E1 byproduct with m/z 285 is believed to correspond to a similar
compound but with a ketone group instead of a hydroxyl group
in position 17, i.e. to 10-hydroxy-1,4-estradieno-3,17-dione
(HEDO).
1540 R. de Oliveira Pereira et al. / Chemosphere 84 (2011) 1535–1541The formation pathway of DEO from E2 has already been sug-
gested by Mai et al. (2008) and according to it the formation path-
way of the above suggested E1 byproduct would be the same.
It may be worth mentioning that the pH of the samples (mea-
sured at the beginning and at the end of the experiments) de-
creased as the formation of the byproducts increased (following
the loss of H+ and the addition of OH in the molecule) and vice ver-
sa, as it is shown in Supplementary Information-3 for the byprod-
uct with m/z 285.
For the E2 and E1 byproducts withm/z 277 andm/z 275, respec-
tively, the pathway of degradation based on the mechanism of
phenol ozonolysis (Komissarov et al., 2006) is suggested. This path-
way is illustrated in Fig. 5 for E2. The pathway for E1 would be sim-
ilar but maintaining the ketone group that is present in position 17
in the original E1 structure. Fig. 6 shows the product ion mass
spectra and the purported fragmentation of the byproducts with
m/z 277 and m/z 275 that support the proposed structures.
The ﬁnding of these byproducts, not reported previously by
other authors, could be due to the use of different equipments
and/or experimental conditions. In the works performed by Bila
et al. (2007) and Maniero et al. (2008) the ozone doses and the ini-
tial concentration of E2 were comparable to those used in the pres-
ent study but the identiﬁcation of byproducts was carried out by
GC/MS. In the work conducted by Irmak et al. (2005) the detection
of byproducts was performed by LC–MS/MS but the conditions of
the experiment were very different from ours with higher initial
estrogen concentrations and unclear doses of ozone consumed. An-
other possible difference could be the reactive form triggering the
process in each work, which in our study, conducted at pH around
7, would be basically molecular ozone and in other studies OH
radicals.
The ozonation experiments carried out at lower initial concen-
trations of the estrogens (100 ng L1) were conducted with the
double objective of, ﬁrst, conﬁrming the formation of the previ-
ously identiﬁed main byproducts at concentrations in water closer
to those found in the environment and, secondly, determining the
ozone dosage that would have to be applied to remove them. Fig. 7
shows the evolution of the targeted byproducts during the ozona-Fig. 7. Formation and degradation of the main E2 (A) and E1 (B) byproducts during
ozonation. Initial concentration of estrogens in water 100 ng L1.tion experiments. As it can be seen, some byproducts were formed
and reached their maximum concentration at an ozone dosage of
approximately 0.5 mg O3 L1, decreasing afterwards. Compara-
tively, the E2 byproducts, that persisted until an ozone dosage of
16 mg O3 L1, were more recalcitrant than the E1 byproducts, that
disappeared at a lower ozone dosage of 10 mg O3 L1.
The E2 and E1 byproducts with m/z 287 and m/z 285, respec-
tively, had the same behavior, being both completely removed (be-
low equipment detection limits) after an ozone dosage of 4 mg
O3 L1 (Fig. 7). The E1 byproduct with m/z 275 and the E2 byprod-
uct with m/z 277 remained longer in the solution, until the ozone
dosage reached 10 and 16 mg O3 L1, respectively.
Several authors that have investigated the estrogenicity of dis-
infected waters have observed estrogenic activity after water ozon-
ation (Alum et al., 2004; Huber et al., 2004; Kim et al., 2004;
Maniero et al., 2008), indicating the occurrence of byproducts
and that these byproducts are also biologically active even after
application of high ozone dosages. An increase in the concentration
of ozone from 0.5 to 10 mg L1 has been shown to reduce the estr-
ogenicity of the original water by a factor of 200–1000 (Huber
et al., 2004). This residual estrogenicity, although low, may still
be relevant if we consider that water is just one of many possible
routes of exposure to estrogenic compounds.4. Conclusions
E2 and E1 have shown to be efﬁciently removed from water
through ozonation, but to form each of them two major byprod-
ucts. These byproducts with MM 288 and 278, and 286 and 276,
respectively, have been tentatively identiﬁed (the last three for
the ﬁrst time) by means of UPLC–QqTOF-MS/MS. E2 and E1 are be-
lieved to follow the same degradation pathway since their corre-
sponding byproducts, alike them, differ in two mass units. The
total elimination of these byproducts occurred only with high
ozone dosages (10 mg and 16 mg O3 L1 for the E1 and E2 byprod-
ucts, respectively).
The ozonation byproducts can pose a risk not only to drinking
water consumers but also to aquatic organisms that can become
exposed to them through reclaimed water having been subjected
to ozonation or when ozone treated wastewater is released into
the environment. Thus, for a proper evaluation of the risk associ-
ated to the use of ozonized water, the ecotoxicity and estrogenicity
of the byproducts should be evaluated.Acknowledgments
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